From: Evaluation of creatine kinase and liver enzymes in identification of severe dengue
 | All | Severe Dengue | Non-severe Dengue | p-value | |||
---|---|---|---|---|---|---|---|
n | No. (% or IQR) | n | No. (% or IQR) | n | No. (% or IQR) | ||
Gender | 365 | Â | Â | Â | Â | Â | 0.003a |
Male | Â | 215 (58.90%) | 22 | 6 (2.80%) | 343 | 209 (97.20%) | Â |
Female | Â | 150 (41.10%) | 22 | 16 (10.70%) | 343 | 134 (89.30%) | Â |
Age (y), median (IQR) | 364 | 28 (23 - 36) | 22 | 31 (23 - 36) | 342 | 28 (23 - 36) | 0.660b |
BMI, median (IQR) | 353 | 24 (21 - 28) | 18 | 25 (21 - 29) | 335 | 24 (21 - 28) | 0.700b |
Co-morbids present | 365 | 55 (15.10%) | 22 | 8 (36.40%) | 343 | 47 (13.70%) | 0.009a |
DM | 365 | 12 (3.30%) | 22 | 3 (13.60%) | 343 | 9 (2.60%) | 0.003a |
Hypertension | 365 | 16 (4.40%) | 22 | 3 (13.60%) | 343 | 13 (3.80%) | 0.006a |
Other co-morbids | 365 | 49 (13.40%) | 22 | 6 (27.30%) | 343 | 43 (12.50%) | 0.100a |
Number of co-morbids | 365 | Â | 22 | Â | 343 | Â | 0.003c |
0 | Â | 308 (84.40%) | 22 | 14 (63.60%) | 343 | 294 (85.70%) | Â |
1 | Â | 41 (11.20%) | 22 | 5 (22.70%) | 343 | 36 (10.50%) | Â |
2 | Â | 12 (3.30%) | 22 | 2 (9.10%) | 343 | 10 (2.90%) | Â |
3 | Â | 4 (1.10%) | 22 | 1 (4.50%) | 343 | 3 (0.90%) | Â |
More than 1 co-morbids present | 365 | 16 (4.40%) | 22 | 3 (13.60%) | 343 | 13 (3.80%) | 0.006a |